First Health Advisory Announces Rick LeMay as Executive Vice President of Enterprise Security & Technology

First Health Advisory recently welcomed Rick LeMay as its Executive Vice President of Enterprise Security & Technology to help advance the company's mission of providing digital health risk assurance to healthcare organizations.

Safer Covid disinfectant for thousands of aircraft

King Abdullah University of Science and Technology (KAUST) biotech spinout WAYAKIT’s safe, QAC-free disinfectant is being used on thousands of aircraft through new Saudi Ground Services (SGS) cleaning partnership.

BioTeam Secures 5-Year Contract to Lead NEI’s Scientific IT Transformation

BioTeam Inc., a scientific computing consulting company, today announced that it has been awarded a 5-year (one base year of $3.3M plus four option years) contract by the National Eye Institute (NEI). BioTeam will lead and operate NEI’s Office of the Scientific Information Officer to provide NEI with scientific IT leadership and strategy and support in bioinformatics, scientific IT infrastructure development, data management, and scientific IT operations.

Sygnature Discovery collaborates with Axol Bioscience to utilize human iPSC-derived microglial cells in high-content imaging drug discovery screening workflows

Quotient Sciences Announces Successful US FDA Inspection of Alnwick, UK Facility

DLOC Biosystems chooses Discovery Park for new biology facility to develop organ-on-a-chip technology

LOC Biosystems has selected Discovery Park, Kent, as the location for its new biology facility. The company will set up a biology lab within Discovery Park’s thriving life science cluster to continue development of its state-of-the-art organ-on-a-chip technology and deliver accurate assay testing services to pharmaceutical companies to advance drug discovery.

Fuzion by DrFirst Brings Radical Efficiency to Clinical Workflows and Safeguards Patients from Preventable Errors

Fuzion by DrFirst Brings Radical Efficiency to Clinical Workflows and Safeguards Patients from Preventable Errors

Veradigm Joins FDB Vela ePrescribing Network to Offer Prescribers & Patients Greater Choice, Cost Transparency

Veradigm Joins FDB Vela ePrescribing Network to Offer Prescribers & Patients Greater Choice, Cost Transparency

X-Chem and Structural Genomics Consortium Enter Into Collaboration to Unlock the Human Proteome and Promote Open Science

Sharp acquires Berkshire Sterile Manufacturing

Firstsource Positioned as a ‘Leader’ and a ‘Star Performer’ in Everest Group Healthcare Payer Operations PEAK Matrix® Assessment 2023

About Firstsource Firstsource Solutions Limited, an RP-Sanjiv Goenka Group company (NSE: FSL, BSE: 532809, Reuters: FISO.BO, Bloomberg: FSOL:IN), is a leading provider of transformational solutions and services spanning the customer lifecycle across Healthcare, Banking and Financial Services, Communications, Media and Technology, and other industries. The Company’s ‘Digital First, Digital Now’ approach helps organizations reinvent operations and reimagine business models, enabling them to deliver moments that matter and build competitive advantage. With an established presence in the US, the UK, Mexico, India, and the Philippines, Firstsource acts as a trusted growth partner for over 150 leading global brands, including several Fortune 500 and FTSE 100 companies. (www.firstsource.com)

InsightRX to Present Multiple Studies Demonstrating Advances in Precision Medicine at IDWeek 2023

InsightRX to Present Multiple Studies Demonstrating Advances in Precision Medicine at IDWeek 2023 - Recent research highlights the potential for model-informed precision dosing to improve patient safety, enhance clinical practice and reduce the cost of care

Phastar Net-Zero Target Approved by the Science Based Targets Initiative

Phastar Net-Zero Target Approved by the Science Based Targets Initiative Phastar commits to achieving Net-Zero Standard by 2035

Almaden Genomics Adds Pre-Built Workflows to g.nome, Facilitating and Speeding Single-Cell RNA-seq Analysis

Almaden Genomics has added pre-built workflows for single-cell RNA-seq analysis to its g.nome™ platform, enabling understanding of cellular diversity and disease mechanisms on a much more granular level. By unlocking single-cell sequencing data through efficient and powerful analysis, g.nome can now help researchers better understand cellular heterogeneity and gene expression.

AVIA’s National Generative AI Collaborative Grows to Nearly Thirty Major Health Systems

BioIVT Elevates Cell and Gene Therapy to an Artform at Meeting on the Mesa

Expert staff will be on hand at the conference to discuss how BioIVT can support CGT research from discovery and development to commercialization.

BioIVT to Host a Webinar on Optimizing Liquid Biopsy Research

This webinar will discuss the importance of using standardized collection protocols and a diverse donor base to validate biomarkers and ensure their clinical utility.

Scitara and IDT present a composable IT architecture platform at Lab of The Future Europe 2023

Emendo Biotherapeutics Leaders Share Expert Insights on Cutting-Edge Gene Editing Advancements at October Industry Conferences

Executive Team Charts Path to Future Approval as the World Awaits a Historic Breakthrough in Precision Medicine

Takara Bio enters into a license agreement of RetroNectin® with Fondazione Telethon ETS

Takara Bio Inc. has announced that it has entered into a License Agreement with non-profit/charity organization, Telethon.